Skip to main content
Springer Nature Link
Log in

Prophylaxis in idiopathic calcium urolithiasis

  • Published:
Urological Research Aims and scope Submit manuscript

Summary

The most important measure in the prophylaxis of idiopathic calcium urolithiasis is dietary advice. Patients should be kept to a high-fluid intake, increasing their diuresis by at least 0.51. The mineral content of drinking water seems to be of minor importance, but the liquid should be low in carbohydrates and oxalate. The intake of animal proteins should be reduced to no more than five meals with meat, fish or poultry per week. Excesses of oxalate-rich food must be avoided. The daily intake of calcium in dairy products should be in the range of 800–1200 mg. Sodium and refined carbohydrates should be moderately restricted. Medical treatment is indicated only in cases of recurrence under the appropriate diet. Selective treatment according to urinary chemical composition is favoured; alkali citrate, thiazides, allopurinol, and pyridoxine are of major interest.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ackermann D, Baumann JM, Futterlieb A, Zingg EJ (1988) Influence of calcium content in mineral water on chemistry and crystallization conditions in urine of calcium stone formers. Eur Urol 14:305

    Google Scholar 

  2. Backman U, Danielson BG, Johansson G, Ljunghall S, Wikström B (1980) Treatment of recurrent calcium stone formation with cellulose phosphate. J Urol 123:9

    Google Scholar 

  3. Brocks P, Dahl C, Wolf H, Transbol I (1981) Do thiazides prevent recurrent idiopathic calcium stones? Lancet II:124

    Google Scholar 

  4. Butz M, Schwab G (1990) Alkalicitrate versus diet: a randomized long-term trial in recurrent calcium stone formers. In: Vahlensieck W, Gasser G, Hesse A, Schoencich G (eds) Proceedings of the 1st European Symposium on Urolithiasis. Excerpta Medica, Amsterdam Hong Kong Princeton Sydney Tokyo, p 184

    Google Scholar 

  5. Churchill DN (1987) Medical treatment to prevent recurrent calcium urolithiasis. Miner Electrolyte Metab 13:294

    Google Scholar 

  6. Churchill DN, Taylor DW (1985) Thiazides for patients with recurrent calcium stones: still an open question. J Urol 133:749

    Google Scholar 

  7. Classen A, Busch B, Gertz B, Weber A, Miersch WD, Hesse A (1989) Dietary fiber and urolithiasis: II. Effects of a high dietary fiber intake on the urine composition in man. In: Walker VR, Sutton RAL, Cameron ECB, Pak CJC, Robertson WG (eds) Urolithiasis. Plenum Press, New York London, p 869

    Google Scholar 

  8. Danielson BG, Fellström B, Wikström B (1989) Glycosaminoglycans as inhibitors of renal stone formation. In: Walker VR, Sutton RAL, Cameron ECB, Pak CYC, Robertson WG (eds) Urolithiasis. Plenum Press, New York London, p 101

    Google Scholar 

  9. Ebisuno S, Morimoto S, Yoshida T, Fukatani T, Yasukawa S, Ohkawa T (1986) Rice-bran treatment for calcium stone formers with idiopathic hypercalciuria. Br J Urol 58:592

    Google Scholar 

  10. Ettinger B (1976) Recurrent nephrolithiasis: natural history and effect of phosphate therapy. Am J Med 61:200

    Google Scholar 

  11. Ettinger B, Tang A, Citron JT, Livermore B, Williams T (1986) Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 315:1386

    Google Scholar 

  12. Ettinger B, Citron JT, Livermore B, Domant LI (1988) Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol 139:679

    Google Scholar 

  13. Gill HS, Ros GA (1986) Mild metabolic hyperoxaluria and its response to pyridoxine. Urol Int 41:393

    Google Scholar 

  14. Goldfarb S (1988) Dietary factors in the pathogenesis and prophylaxis of calcium nephrolithiasis. Kidney Int 34:544

    Google Scholar 

  15. Hosking DH, Erickson SB, Berg CJ von den, Wilson DM, Smith LH (1983) The stone clinic effect in patients with idiopathic calcium urolithiasis. J Urol 130:1115

    Google Scholar 

  16. Jaeger P, Portmann L, Jacquet AF, Burckhardt P (1984) Drinking water for stone formers: is the calcium content relevant? Eur Urol 10:53

    Google Scholar 

  17. Jaeger P, Portmann L, Jacquet AF, Burckhardt P (1985) Influence of the calcium content of the diet on the incidence of mild hyperoxaluria in idiopathic renal stone formers. Am J Nephrol 5:40

    Google Scholar 

  18. Lacrum E, Larsen S (1985) Thiazide prophylaxis of urolithiasis: a double blind study in general practice. In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W (eds) Urolithiasis and related clinical research. Plenum Press, New York London, p 475

    Google Scholar 

  19. Li MK, Kavanagh JP, Prendiville V, Buxton A, Moss DG, Blacklock NJ (1986) Does sucrose damage kidneys? Br J Urol 58:353

    Google Scholar 

  20. Ljunghall S (1985) Incidence of renal stones in Western countries. In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W (eds) Urolithiasis and related clinical research. Plenum Press, New York London, p 31

    Google Scholar 

  21. Ljunghall S, Fellström P, Johansson G (1988) Prevention of renal stones by a high fluid intake? Eur Urol 14:381

    Google Scholar 

  22. Marks RG (1982) Designing a research project. Van Nostrand Reinhold, New York, p 124

    Google Scholar 

  23. Minano L, Petta S, Paradiso Galatioto G, Goldoni S, Tubaro A (1985) A placebo controlled double-blind study of allopurinol in severe recurrent idiopathic renal lithiasis. Preliminary results. In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W (eds) Urolithiasis and related clinical research. Plenum Press, New York London, p 521

    Google Scholar 

  24. Mortensen JT, Schultz A, Ostergaard AH (1986) Thiazides in the prophylactic treatment of recurrent idiopathic kidney stones. Int Urol Nephrol 18:265

    Google Scholar 

  25. Nakada T, Sasagawa I, Furuta H, Katayama T, Shimazaki J (1988) Effect of high-calcium diet on urinary oxalate excretion in urinary stone formers. Eur Urol 15:264

    Google Scholar 

  26. Pak CYC, Nicar MJ, Britton F (1983) Clinical experience with sodium cellulose phosphate. World J Urol 1:180

    Google Scholar 

  27. Pak CJC, Fuller C, Sakhaee K, Preminger GM, Britton F (1985) Long-term treatment of calcium nephrolithiasis with potassium citrate. J Urol 134:11

    Google Scholar 

  28. Pierce LW, Bloom B (1945) Observations on urolithiasis among American troops in a desert area. J Urol 54:466

    Google Scholar 

  29. Rao PN, Gordon C, Davis D, Blacklock NJ (1982) Are stone formers maladapted to refined carbohydrates? Br J Urol 54:575

    Google Scholar 

  30. Rao PN, Jenkins IL, Robertson WG, Peacock M, Blacklock NJ (1985) The effect of “high fibre biscuits” on urinary risk factors for stone formation. In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W (eds) Urolithiasis and related clinical research. Plenum Press, New York London, p 425

    Google Scholar 

  31. Robertson WG, Peacock M (1980) The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria? Nephron 26:105

    Google Scholar 

  32. Robertson WG, Peacock M (1982) The pattern of urinary stone disease in Leeds and in the United Kingdom in relation to animal protein intake during the period 1960–1980. Urol Int 37:394

    Google Scholar 

  33. Robertson WG, Peacock M, Heyburn PJ, Marshall DH, Clark PB (1978) Risk factors in calcium stone disease of the urinary tract. Br J Urol 50:449

    Google Scholar 

  34. Robertson WG, Peacock M, Heyburn PJ, Hanes FA (1980) Epidemiological risk factors in calcium stone disease. Scand J Urol Nephrol 53:15

    Google Scholar 

  35. Robertson WG, Peacock M, Selby PL, Williams RE, Clark P, Chisholm GD, Hargreaves TB, Rose MB, Wilkinson H (1985) A multicentre trial to evaluate three treatments for recurrent idiopathic calcium stone disease — a preliminary report. In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W (eds) Urolithiasis and related clinical research. Plenum Press, New York London, p 545

    Google Scholar 

  36. Scholz D, Schwille PO, Sigel A (1982) Double-blind study with thiazide in recurrent calcium lithiasis. J Urol 128:903

    Google Scholar 

  37. Shuster J, Finlayson B, Schaeffer R, Sierakowski R, Zoltek J, Dzegede S (1982) Water hardness and urinary stone disease. J Urol 128:422

    Google Scholar 

  38. Shuster J, Finlayson B, Schaefer L, Sierakowski R, Zoltek J, Dzegede S (1985) Primary liquid intake and urinary stone disease. J Chronic Dis 38:907

    Google Scholar 

  39. Smith MJV (1977) Placebo versus allopurinol for renal calculi. J Urol 117:690

    Google Scholar 

  40. Strauss AL, Coe FL, Deutsch L, Parks JH (1982) Factors that predict relapse of calcium nephrolithiasis during treatment. Am J Med 72:17

    Google Scholar 

  41. Strohmaier WL, Kalchthaler M, Bichler KH (1989) Calcium metabolism in normal subjects and in hypercalciuric patients treated with Farnolith. In: Walker VR, Sutton RAL, Cameron ECB, Pak CJC, Robertson WG (eds) Urolithiasis. Plenum Press, New York London, p 873

    Google Scholar 

  42. Thomas WC (1978) Use of phosphates in patients with calcareous renal calculi. Kidney Int 13:390

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, University Hospital, Berne, Switzerland

    D. Ackermann

Authors
  1. D. Ackermann
    View author publications

    You can also search for this author inPubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ackermann, D. Prophylaxis in idiopathic calcium urolithiasis. Urol. Res. 18, S37–S40 (1990). https://doi.org/10.1007/BF00301526

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00301526

Key words